Rivero GI

Language: Spanish
References: 10
Page: 297-301
PDF size: 191.98 Kb.

ABSTRACT

Chagas’ Disease or American tripanosomiasis is a zoonosis product of the infection by the protozoan Trypanosoma cruzi. As its name suggests the disease it is native to America, affecting aproximately 5.7 million people and causing some 20 thousand deaths per year. It is also the third most common parasitosis, only surpassed by malaria and shistosomiasis. Infection is lifelong in the absence of an adequate and early treatment.

REFERENCES

1. Anis Rassi, Jr. Et al. Development and Validation of a Risk Score for Predicting Death in Chagas’ Heart Disease. N Engl J Med 2006; 355:799-808, August 24, 2006

2. Carlos A. Morillo, et al. Randomized Trial of Benznidazole for Chronic Chagas’ Cardiomyopathy. N Engl J Med 2015; 373:1295-1306, October 1, 2015.

3. Caryn Bern. Antitrypanosomal Therapy for Chronic Chagas’ Disease. N Engl J Med 2011; 364:2527-2534, June 30 2011.

4. Caryn Bern. Chagas’ Disease. N Engl J Med 2015; 373:456-466, July 30, 2015.

5. Ernestina Carla Repetto, et al. Neglect of a Neglected Disease in Italy: The Challenge of Accessto- Care for Chagas Disease in Bergamo Area. PloS One. Published: September 25, 2015, DOI: 10.1371/ journal.pntd.0004103

6. Farreras, Rozman. Medicina Interna. Enfermedad de Chagas. Edicion 17.

7. Longo D. et al. Harrison, Principios de Medicina Interna. Enfermedad de Chagas y Tripanosomiasis. 2012. Edición 18.

8. Lowell A. Goldsmith et al. Fitzpatrick’s Dermatology In General Medicine. Chagas’Disease. 2012. Eight Edition.

9. María-Jesús Pinazo, et al. Immunosuppression and Chagas Disease: A Management Challenge. PloS One. January 17, 2013, DOI: 10.1371/journal.pntd.0001965.

10. Pedro Albajar-Viñas, et at. Advancing the Treatment for Chagas’ Disease. N Engl J Med 2014; 370:1942-1943, May 15, 2014.